Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

被引:76
作者
Chantelau, E [1 ]
机构
[1] Heinrich Heine Univ, MNR Klin, Diabet Ambulanz, Dept Med, D-40001 Dusseldorf, Germany
关键词
D O I
10.1136/bjo.82.7.725
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background-Acute reduction of chronic hyperglycaemia can accelerate early diabetic retinopathy. In adolescent patients with Mauriac's syndrome, this phenomenon is related to an upregulation of subnormal serum IGF-1 levels. Aim-To obtain longitudinal data on serum IGF-I and retinopathy status in poorly controlled adult insulin dependent (type I) diabetic patients without Mauriac's syndrome, in whom hyperglycaemia is reduced by intensive insulin therapy. Methods-Four patients with chronic severe insulin deficiency and early microangiopathy were studied prospectively. Changes in plasma glucose, HbA(1c), serum IGF-I levels, proteinuria, retinopathy, and clinical status were followed up closely. Results-Reducing hyperglycaemia from >16 mmol/l (equivalent to HbA(1c) >11%) to <10 mmol/l (HbA(1c) <8%) within 5 months increased serum IGF-1. levels by 70-220%. While proteinuria and symptomatic neuropathy regressed, retinopathy progressed from the mild to the severe nonproliferative stage with maculopathy (n=4), and to the proliferative stage (n=1). Laser coagulation was commenced upon the appearance of sight threatening macular oedema (n=4). Conclusion-Upregulation of serum IGF-1 preceding retinal deterioration in these patients suggests a cause-effect relation, consistent with earlier experimental and clinical data.
引用
收藏
页码:725 / 730
页数:6
相关论文
共 39 条
[1]  
Agardh Carl-David, 1992, Journal of Diabetes and its Complications, V6, P96, DOI 10.1016/1056-8727(92)90018-G
[2]   HYPOXIC REGULATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR IN RETINAL CELLS [J].
AIELLO, LP ;
NORTHRUP, JM ;
KEYT, BA ;
TAKAGI, H ;
IWAMOTO, MA .
ARCHIVES OF OPHTHALMOLOGY, 1995, 113 (12) :1538-1544
[3]  
ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281
[4]  
ALMRAYAT M, 1997, DIABETIC MED S4, V14, pS39
[5]  
Averbukh E., 1997, Diabetologia, V40, pA493
[6]   INSULIN-LIKE GROWTH FACTOR-(IGF)-I AND FACTOR-(IGF)-II IN DIABETIC PREGNANCY - SUPPRESSION OF NORMAL PREGNANCY-INDUCED RISE OF IGF-I [J].
BHAUMICK, B ;
DANILKEWICH, AD ;
BALA, RM .
DIABETOLOGIA, 1986, 29 (11) :792-797
[7]   Intravitreal growth factors in proliferative diabetic retinopathy: Correlation with neovascular activity and glycaemic management [J].
Boulton, M ;
Gregor, Z ;
McLeod, D ;
Charteris, D ;
JarvisEvans, J ;
Moriarty, P ;
Khaliq, A ;
Foreman, D ;
Allamby, D ;
Bardsley, B .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1997, 81 (03) :228-233
[8]   Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy [J].
Burgos, R ;
Simo, R ;
Audi, L ;
Mateo, C ;
Mesa, J ;
GarciaRamirez, M ;
Carrascosa, A .
DIABETOLOGIA, 1997, 40 (09) :1107-1109
[9]  
CARROLL PB, 1992, ACTA PAEDIAT, V8, P355
[10]  
Chantelau E, 1997, BMJ-BRIT MED J, V315, P1105